The Swiss biotech industry continued to grow in 2017. Reaching record figures in sales and capital investments in companies, according to a new report. New…
Targeted protein degradation is really taking off. Besides Arvinas, C4 Therapeutics, and Kymera, Cedilla Therapeutics, founded by Thirdrock Ventures, has emerged with a $56 million…
A short review A year ago, BaselArea.swiss presented BaseLaunch at a fully booked launch event in Basel, Switzerland. Guests from the healthcare industry, research, academia…